Anti-VEGF Treatment Strategies for Wet AMDReport as inadecuate

Anti-VEGF Treatment Strategies for Wet AMD - Download this document for free, or read online. Document in PDF available to download.

Journal of OphthalmologyVolume 2012 2012, Article ID 786870, 7 pages

Review Article

Department of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami, 311 9th St North, Naples, FL 34102, USA

Penn State Hershey Eye Center, Hershey, PA 17033, USA

Received 1 July 2011; Revised 20 September 2011; Accepted 23 October 2011

Academic Editor: James T. Handa

Copyright © 2012 Jaclyn L. Kovach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Over the past few years, antivascular endothelial growth factor VEGF therapy has become a standard treatment for neovascular age-related macular degeneration AMD. During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

Author: Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn Jr., and Ingrid U. Scott



Related documents